Coronary heart disease in children with familial hypercholesterolemia: Maximum therapy with LDL apheresis;Koronare herzrankheit im kindesalter bei familiärer hypercholesterinämie: Maximaltherapie unter einsatz der LDL-apherese

Internist

Volumn 44, Issue 4, 2003, Pages 476-480

  Mellwig, K P ^a   Schmidt, H K ^a   Brettschneider Meyer, A ^a   Meyer, H ^a   Jaeger, B R ^b   Walli, A K ^b   Seidel, D ^b   Horstkotte, D ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Childhood; Coronary heart disease; Dysfunctional lipid metabolism; Familial hypercholesterolemia; LDL apheresis

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ANGIOCARDIOGRAPHY; APHERESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ERGOMETRY; FAMILIAL HYPERCHOLESTEROLEMIA; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID ANALYSIS; MALE; PLASMA VISCOSITY; PROGNOSIS; SCHOOL CHILD;

EID: 0037395096     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-002-0832-1     Document Type: Article

References (11)

1. Gröne HJ, Walli AK, Krämer A, Reuter C, Seidel D (1990) Receptor-mediated uptake of Apo Band Apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int 37: 1449-1459
2. Mellwig KP, Baller D, Gleichmann U, Moll D, Betker S, Weise R, Notohamiprodjo G (1998) Improvement of coronary vasodilatation capacity through single LDL-apheresis. Atherosclerosis 139: 173-178
3. Moll D, Mellwig KP, Ziemssen P, Baller D, Gleichmann U, Holzinger J, Notohamiprodjo G, Horstkotte D (1999) Klinische Bedeutung einer Verbesserung der koronaren Vasodilatationskapazität durch einmalige LDL-Apherese. Z Kardiol 88 (Suppl): 303
4. National Cholesterol Education Program (1992) Highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89: 495-501
5. Schuff-Werner P, Gohlke H, Bartmann U et al. and the HELP-Study Group (1994) The HELP-apheres multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. Eur J Clin Invest 24: 724-732
6. Schuff-Werner P, Schütz E, Seyde WC, Eisenhauer T, Jannings G, Armstrong VW, Seidel D (1989) Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (H.E.L.P.), Eur J Clin Invest 19: 30-37
7. Sprecher DL, Schaefer EJ, Kent KM (1984) Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 54: 20-30
8. Stefanutti C, Vivenzio A, Colombo C et al. (1995) Treatment of homozygous and double heterozygous familial hypercholesterolemic children with LDL-apheresis. Int J Artif Organs 18: 103-110
9. Stefanutti C, Notarbartolo A, Colloridi V et al. (1997) LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5. Artif Organs 21: 1126-1127
10. Wieland H, Seidel D (1983) A simple specific method for precipitation of low density lipoproteins. J Lipid Res 24: 904-909
11. Zwiener PJ, Uauy R, Petruska ML, Huet BA (1995) Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia. J Pediatr 126: 728-735